Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial

Volume: 97, Issue: 5, Pages: 976 - 985
Published: Apr 1, 2017
Abstract
Purpose null SpaceOAR, a Food and Drug Administration–approved hydrogel intended to create a rectal–prostate space, was evaluated in a single-blind phase III trial of image guided intensity modulated radiation therapy. A total of 222 men were randomized 2:1 to the spacer or control group and received 79.2 Gy in 1.8-Gy fractions to the prostate with or without the seminal vesicles. The present study reports the final results with a median...
Paper Details
Title
Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial
Published Date
Apr 1, 2017
Volume
97
Issue
5
Pages
976 - 985
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.